Specialist Biotech Investor
What Is Institutional Ownership in Biotech? Why It Matters for Retail Investors
When a well-known healthcare-focused hedge fund or a specialized biotech mutual fund takes a significant position in a clinical-stage company, retail investors often take notice — and for good reason. Institutional investors in biotech frequently employ dedicated scientific and clinical staff, including MDs and PhDs, to conduct deep diligence on clinical trial design, competitive landscape,…
